BioBlood Final Symposium

BSELBioBlood Final Symposium, 20 April 2018, Imperial College London:

LOGO1

Engineering a Bone Marrow Biomimicry

 

Keynote 1: Current challenges in the management of Acute Myeloid Leukaemia – Prof. C. Craddock; Queen Elizabeth Hospital, University of Birmingham:

In vitro erythropoiesis in a 3D bone marrow biomimicry – S. Brito dos Santos; BSEL, Imperial College London:

Engineering of a perfused hollow fibre bioreactor for human erythropoiesis – Prof. A. Mantalaris; BSEL, Imperial College London:

Towards personalised healthcare – developing a 3D leukaemia biomimicry – J. dos Santos; BSEL, Imperial College London:

Mathematical Model to Predict Chemotherapy Outcomes – Dr. A. Quiroga-Campano; BSEL, Imperial College London:

Keynote 2: Transcriptional regulation of erythropoiesis – Prof. J. Strouboulis; Institute of Molecular Biology and Biotechnology, Crete, Greece:

The Immune-metabolism of Acute Myeloid Leukaemia – Dr. S. Zemenides; BSEL, Imperial College London:

 

Keynote 3: Megakaryocytic microparticles for cell- and gene-therapies – Prof. T. Papoutsakis, University of Delaware, USA:

 

NHS

RichardT